SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

CUSIP: 868459108

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
57,572,193
Total 13F shares
46,114,534
Share change
+6,806,107
Total reported value
$1,443,390,915
Put/Call ratio
101%
Price per share
$31.30
Number of holders
244
Value change
+$218,131,286
Number of buys
126
Number of sells
107

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q1 2017

As of 31 Mar 2017, SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by 244 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,114,534 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Bank of New York Mellon Corp, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Ranger Investment Management, L.P., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, ROTHSCHILD ASSET MANAGEMENT INC, and RICE HALL JAMES & ASSOCIATES, LLC. This page lists 244 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.